So, IL-6/JAK/STAT3 signaling is believed as a key signaling pathway for tumor progression, and has been confirmed in many types of solid tumors such as HCC [57], breast cancer [58] and lung adenocarcinomas [59]. This evidence concerns the gene IL6 and breast carcinoma.